Assessment of 213Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-13C]pyruvate and [18F]FDG.
Sci Rep
; 9(1): 8294, 2019 06 05.
Article
in En
| MEDLINE
| ID: mdl-31165773
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Carcinoma
/
Urothelium
/
Pyruvic Acid
/
Fluorodeoxyglucose F18
/
Antibodies, Monoclonal
Limits:
Humans
Language:
En
Journal:
Sci Rep
Year:
2019
Document type:
Article
Affiliation country:
Germany
Country of publication:
United kingdom